Press release
SmythOS Announces Former OpenAI Trust & Safety Specialist Joining Leadership Team
SmythOS [https://smythos.com/], a GenAI app orchestration framework for rapid, secure and visual AI agent development, is thrilled to announce the appointment of Ishant Singh Chauhan, a former key member of OpenAI's trust and safety team, as its new Director of Customer Success.
Ishant, who has a distinguished track record in enhancing customer engagement and implementing advanced safety protocols in AI technologies, will bring a wealth of expertise and leadership to SmythOS.
From 2021 to 2023, Ishant served as the AI Safety Specialist - Trust & Safety at OpenAI where he played a pivotal role in developing relationships with the first 2000+ clients.
During his tenure at OpenAI, Ishant played a pivotal role in advancing the safety and security frameworks of Applied AI technologies. His experience in automated safety solutions, product policies, and risk evaluations is an invaluable asset to our organization.
During his tenure, more than 2,000 customers, including many renowned F100 enterprises, successfully adopted OpenAI's cutting-edge AI solutions.
Since exiting OpenAI, Ishant Singh [https://www.linkedin.com/in/ishant-singh-chauhan/] gained further recognition as the CEO of an AI startup, an AI agent company he sold in March 2024. Business Insider ran a story on him and 18 other ex-OpenAI employees who became successful AI entrepreneurs.
Ishant had many options for his next career move. He chose SmythOS - in his words, because "SmythOS understands how to safely deliver on the promise of AI agents better than any other product in the market, with a vision that aligns with everything I know to be true, and a team that I have tracked since my days at OpenAI".
At SmythOS, Ishant will lead the customer success team, focusing on delivering exceptional service and fostering long-term, sustainable partnerships.
His deep understanding of AI applications and unwavering commitment to customer safety will be invaluable as SmythOS continues to expand its reach and push the boundaries of AI innovation.
"We are excited to welcome Ishant to our team," said Michael Umansky, CEO of INK Content, owner of SmythOS. "His exceptional track record in AI safety and customer engagement will be pivotal in our continued commitment to delivering trustworthy and safe AI orchestration."
About SmythOS:
SmythOS is an AI leader in AI agent orchestration. It allows anyone to seamlessly integrate AI, APIs, and data sources through its drag-and-drop, no-code platform.
For more information about SmythOS, please visit our website: https://smythos.com/
Watch the Smythos Teaser on YouTube [https://www.youtube.com/watch?v=W8OY5AR49ow].
Video: https://www.youtube.com/embed/W8OY5AR49ow
Media Contact
Company Name: SmythOS by INK Content, Inc.
Contact Person: Pam Weber
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=smythos-announces-former-openai-trust-safety-specialist-joining-leadership-team]
City: Houston
State: Texas
Country: United States
Website: http://smythos.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SmythOS Announces Former OpenAI Trust & Safety Specialist Joining Leadership Team here
News-ID: 3481773 • Views: …
More Releases from ABNewswire
Active Implantable Medical Devices Market Is Expected to Reach USD 44,906.36 mil …
The leading companies operating in the active implantable medical devices market include Medtronic, Johnson and Johnson Services, Inc., Abbott, Boston Scientific Corporation, LivaNova PLC., Axonics, Inc., Aleva Neurotherapeutics, Sonova Holding AG, Bioventus Inc., CARMAT, Jarvik Heart Inc., BIOTRONIK SE & Co. KG, MicroTransponder Inc., MED-EL Medical Electronics, NeuroPace, Inc., NEVRO CORP., Shree Pacetronix, Cochlear Ltd., Berlin Heart, Blackrock Neurotech, and others.
DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape, and…
Global Heparin Market Poised to Reach USD 18.19 Billion by 2032, Driven by Risin …
Major players shaping the global heparin market include Pfizer Inc., Dr. Reddy's Laboratories Ltd., Gland Pharma Limited, Sanofi, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Novartis AG, Baxter, Leo Pharma A/S, and Cardinal Health. Continuous investments in R&D, formulation improvements, mergers, and global distribution partnerships remain vital elements of their growth strategy.
DelveInsight's "Heparin Market Insights, Competitive Landscape, and Market Forecast - 2032" report delivers a comprehensive analysis of…
Global Phage Therapy Pipeline Accelerates as 20+ Biotech Companies Advance Next- …
Key phage therapy companies such as Locus Biosciences, Armata Pharmaceuticals, BiomX, SNIPR Biome, Phagelux, PHAXIAM Therapeutics, Phico Therapeutics, Technophage, and others.
DelveInsight's 'Phage Therapies Competitive Landscape 2025' report provides comprehensive global coverage of pipeline phage therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the phage therapies pipeline domain.
The phage therapy market is witnessing robust growth driven by…
Systemic Juvenile Idiopathic Arthritis Market Analysis 2034 - Competitive Landsc …
Systemic Juvenile Idiopathic Arthritis Companies are Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, Genentech, AbbVie, Pfizer, Eli Lilly and Company, Bristol Myers Squibb, Johnson & Johnson, Merck & Co., UCB, Sanofi, and others.
DelveInsight's "Systemic Juvenile Idiopathic Arthritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Systemic Juvenile Idiopathic Arthritis, historical and forecasted epidemiology as well as the Systemic Juvenile Idiopathic Arthritis market trends in the…
More Releases for SmythOS
SmythOS - Transforming The AI Economy For A Better Future
A great innovation, SmythOS has designed an AI platform that allows users to create AI agents and use them for various tasks, maintaining a balance between AI and human potential.
Image: https://www.globalnewslines.com/uploads/2025/01/0f3d79a813129e228dd02cb458deaebf.jpg
A groundbreaking AI platform, revolutionizing how humans and AI work together is what SmythOS does. Established in 2017, SmythOS aims to make AI more accessible and intuitive for people around the globe to use for their benefit.
Launching the ChatGPT plugin…
